Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer ...

Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...

He, L., Zhou, Y., Wang, Q.T., Liu, J. and Ma, J.P. (2025) Two Pathological Patterns in Different Stages of the Same Disease. Journal of Biosciences and Medicines, 13, 189-195. doi: ...

At the cutting edge of TIL therapy development, Creative Biolabs offers end-to-end and integrated solutions dedicated to the unique needs of this dis ...

Background Direct-acting antiviral agents (DAAs) can achieve high sustained virologic response (SVR) in chronic hepatitis C (CHC) patients; yet a proportion of patients still experience ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...

Even brief exposure to tobacco smoke can trigger inflammation, weaken immunity, and raise cancer risk in organs far beyond ...

New research challenges theory that the appendix serves no purpose - It was once believed there are no downsides to removing ...

The appendix may play a further role in protecting the gastrointestinal system from invading pathogens. This would explain ...